Insurers Seek One-Year Moratorium On Enforcement Of State Exchange Plan Rules
This article was originally published in The Pink Sheet Daily
Executive Summary
The request is broad in scope and presumably would cover potential compliance actions against health plans that are related to prescription drug access, among other issues.
You may also be interested in...
CMS Takes Tough Stand On Part D Compliance: WellPoint Draws Sanctions
CMS is showing it can be tough on compliance in the Medicare Part D program with its recent sanctions against WellPoint
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.